Mateon Therapeutics Inc Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MATN and buy or sell other stocks, ETFs, and their options commission-free!About MATN
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing.
CEOVuong Trieu, PhD
CEOVuong Trieu, PhD
Employees40
Employees40
HeadquartersAgoura Hills, California
HeadquartersAgoura Hills, California
Founded1988
Founded1988
Employees40
Employees40
MATN Key Statistics
Market cap114.26M
Market cap114.26M
Price-Earnings ratio-21.77
Price-Earnings ratio-21.77
Dividend yield—
Dividend yield—
Average volume131.65K
Average volume131.65K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.11
52 Week high$0.11
52 Week low$0.024
52 Week low$0.024
Stock Snapshot
The current Mateon Therapeutics Inc Common Stock(MATN) stock price is $0.26, with a market capitalization of 114.26M. The stock trades at a price-to-earnings (P/E) ratio of -21.77.
During the trading day, Mateon Therapeutics Inc Common Stock(MATN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Mateon Therapeutics Inc Common Stock(MATN) stock has reached 0, versus its average volume of 131.65K.
Over the past 52 weeks, Mateon Therapeutics Inc Common Stock(MATN) stock has traded between a high of $0.11 and a low of $0.02.
Over the past 52 weeks, Mateon Therapeutics Inc Common Stock(MATN) stock has traded between a high of $0.11 and a low of $0.02.